Valuation : HeraMED Limited

Market Cap 40.55M 29.09M 25.07M 23.51M 21.46M 40.42M 2.78B 279M 109M 1.4B 109M 107M 4.65B P/E 2024
-1.94x
P/E 2025 -9.23x
Enterprise Value 39.18M 28.11M 24.22M 22.71M 20.73M 39.06M 2.69B 269M 105M 1.36B 106M 103M 4.5B EV / Sales 2024
39.6x
EV / Sales 2025 86.1x
Free-Float
74.97%
Yield 2024 *
-
Yield 2025 -

Last Transcript : HeraMED Limited

1 day+2.86%
1 week-5.26%
Current month-2.70%
1 month-2.70%
3 months-7.69%
6 months-5.26%
1 week 0.04
Extreme 0.035
0.04
1 month 0.03
Extreme 0.034
0.04
Current year 0.03
Extreme 0.03
0.06
1 year 0.03
Extreme 0.03
0.06
3 years 0.01
Extreme 0.006
0.08
5 years 0.01
Extreme 0.006
0.34
10 years 0.01
Extreme 0.006
0.34
Manager TitleAgeSince
Chief Executive Officer - 2024-04-08
Director of Finance/CFO - 2024-04-08
Chief Operating Officer - 2022-09-30
Director TitleAgeSince
Director/Board Member 62 2018-08-20
Director/Board Member - 2024-05-09
Chairman - 2024-05-09
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%-5.26%+9.09%-53.85% 29.09M
+2.66%+0.38%-15.51%+15.17% 127B
-0.93%-0.65%-23.17%-1.07% 12.12B
-1.12%-2.72%+87.72%+137.58% 10.6B
+0.28%+1.87%-51.49%-70.20% 4.22B
-0.42%+2.19%-17.88%+50.05% 2.72B
-1.70%-0.78% - - 2.04B
+1.02%-1.48%-34.42%-74.14% 1.78B
-0.45%-2.20%-16.72%-17.14% 1.62B
Average +0.24%-0.85%-7.80%-1.70% 18B
Weighted average by Cap. +1.93%+0.15%-10.46%+19.06%

Financials

2024 2025
Net sales 364K 261K 225K 211K 193K 363K 24.98M 2.51M 978K 12.61M 981K 960K 41.82M 432K 310K 267K 250K 228K 430K 29.6M 2.97M 1.16M 14.94M 1.16M 1.14M 49.54M
Net income -5.49M -3.94M -3.39M -3.18M -2.91M -5.47M -376M -37.76M -14.73M -190M -14.79M -14.47M -630M -4.13M -2.96M -2.55M -2.39M -2.19M -4.12M -283M -28.41M -11.09M -143M -11.13M -10.89M -474M
Net Debt -3.08M -2.21M -1.91M -1.79M -1.63M -3.07M -211M -21.21M -8.27M -107M -8.31M -8.13M -354M -1.37M -983K -847K -795K -725K -1.37M -93.99M -9.43M -3.68M -47.44M -3.69M -3.61M -157M
Logo HeraMED Limited
HeraMED Limited is an Australia-based medical data and technology company. The Company is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The Company offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Company’s proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.
Employees
-
Date Price Change Volume
26-08-31 A$0.0360 +2.86% 12,846
26-08-28 A$0.0350 -2.78% 237,044
26-08-27 A$0.0360 -5.26% 362,999
26-08-26 A$0.0380 0.00% 54,140
26-08-25 A$0.0380 0.00% 829,904